Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase Itchy homolog (ITCH) is an enzyme encoded by the *ITCH* gene on chromosome 20. As a member of the HECT domain-containing family of E3 ubiquitin ligases, it catalyzes the transfer of ubiquitin from an E2 conjugating enzyme to specific substrate proteins—marking them for proteasomal degradation. This process regulates numerous cellular functions including immune responses and signal transduction. In both mouse models ("Itchy" mice) and humans, loss-of-function mutations lead to profound immune system abnormalities—such as lymphoid hyperplasia and multi-organ inflammation—as well as developmental defects like altered growth patterns and craniofacial anomalies. The activity and specificity of ITCH are regulated by phosphorylation events mediated by kinases such as MAPK8/JNK; this controls downstream effects on transcription factors like JUNB. Through interactions with various signaling molecules—including CXCR4, c-Jun family members, NOTCH receptors—it plays a central role at multiple nodes within cell signaling networks relevant to immunity and development.
Drugs or molecules that would target ITCH would likely act by: Modulating its E3 ubiquitin ligase activity to alter substrate degradation. Affecting its regulation by upstream kinases such as MAPK8/JNK pathway components. No approved drugs or clinical candidates specifically modulating ITCH are referenced.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase Itchy homolog (ITCH).